Preliminary evaluation of a new dopamine transporter radioligand for PET imaging:: [18F]FE-PE2I

被引：0
|
作者：
Varrone, A. [1 ]
Schou, M. [1 ]
Takano, A. [1 ]
Steiger, C. [1 ]
Finnema, S. [1 ]
Chalon, S. [2 ]
Emond, P. [2 ]
Guilloteau, D. [2 ]
Gulyas, B. [1 ]
Halldin, C. [1 ]
机构：
[1] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[2] Univ Tours, INSERM, U619, Tours, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2007年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S205 / S205
页数：1
相关论文
共 50 条
  • [41] Kinetic Analysis and Quantification of the Dopamine Transporter in the Non-Human Primate Brain with [11C]PE2I and [18F]FE-PE2I
    Varrone, A.
    Steiger, C.
    Toth, M.
    Takano, A.
    Guilloteau, D.
    Gulyas, B.
    Halldin, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S223 - S223
  • [42] Kinetic analysis and quantification of the dopamine transporter in the non-human primate brain with [11C]PE2I and [18F]FE-PE2I
    Varrone, Andrea
    Toth, Miklos
    Steiger, Carsten
    Takano, Akihiro
    Guilloteau, Denis
    Ichise, Masanori
    Gulyas, Balazs
    Halldin, Christer
    NEUROIMAGE, 2010, 52 : S168 - S168
  • [43] [18F]FE-PE2I DAT correlates with Parkinson's disease duration, stage, and rigidity/bradykinesia scores: a PET radioligand validation study
    Kerstens, Vera S.
    Fazio, Patrik
    Sundgren, Mathias
    Halldin, Christer
    Svenningsson, Per
    Varrone, Andrea
    EJNMMI RESEARCH, 2023, 13 (01)
  • [44] In vitro and in vivo evaluations of an inhibitory effect of dopamine on [18F]FE-PE2I binding to dopamine transporters in rat brains
    Seki, C.
    Tokunaga, M.
    Maeda, J.
    Kodaka, F.
    Kimura, Y.
    Takuwa, H.
    Ikoma, Y.
    Ito, H.
    Suhara, T.
    Higuchi, M.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2017, 37 : 222 - 222
  • [45] [18F]FE-PE2I DAT correlates with Parkinson’s disease duration, stage, and rigidity/bradykinesia scores: a PET radioligand validation study
    Vera S. Kerstens
    Patrik Fazio
    Mathias Sundgren
    Christer Halldin
    Per Svenningsson
    Andrea Varrone
    EJNMMI Research, 13
  • [46] Reliability and validity of visual analysis of [18F]FE-PE2I PET/CT in early Parkinsonian disease
    Bjerken, Sara Af
    Axelsson, Jan
    Larsson, Anne
    Flygare, Carolina
    Remes, Jussi
    Strandberg, Sara
    Eriksson, Linda
    Backstrom, David
    Jakobson Mo, Susanna
    NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (05) : 397 - 406
  • [47] Striatal dopamine transporter imaging: A head-to-head comparison between [123I]FP-CIT SPECT-CT and [18F]FE-PE2I PET-CT
    Thomsen, Gerda
    Brendstrup-Brix, Kristoffer
    Pinborg, Lars
    Law, Ian
    Hasselbalch, Steen
    Biering-Sorensen, Bo
    Knudsen, Gitte
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [48] Fully Automated GMP-Compliant Synthesis of [18F]FE-PE2I
    Bratteby, Klas
    Denholt, Charlotte Lund
    Lehel, Szabolcs
    Petersen, Ida Nymann
    Madsen, Jacob
    Erlandsson, Maria
    Ohlsson, Tomas
    Herth, Matthias Manfred
    Gillings, Nic
    PHARMACEUTICALS, 2021, 14 (07)
  • [49] Preliminary evaluation of the quantification and metabolism in human subjects of the dopamine transporter redioligand [18F]FE-PE21
    Vantone, Andrea
    Nakao, Ryuji
    Amini, Nahid
    Forberg, Anton
    Nag, Sangram
    Farde, Lars
    Halldin, Christer
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 : S70 - S71
  • [50] [18F]LBT-999, a new radioligand to study the dopamine transporter with PET:: Characterization in baboons
    Saba, Wadad
    Schollhorn, M. -A.
    Valette, H.
    Chalon, S.
    Dolle, F.
    Garreau, L.
    Emond, P.
    Deloye, J. B.
    Guilloteau, D.
    Bottlaender, M.
    NEUROIMAGE, 2006, 31 : T132 - T132
12345